- Filed
- Jun 20, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · Jun 20, 2023 | 367.18M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2023 | 367.18M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2023 | 367.18M sh |
| Operating Cash Flow | Q2 2023 · Mar 31, 2023 | −$1.88M |
| Cash And Equivalents | Q2 2023 · Mar 31, 2023 | $246.65K |
| Cash And Equivalents | Q2 2023 · Sep 30, 2022 | $364.02K |
| Stockholders Equity | Q2 2023 · Mar 31, 2023 | $9.14M |
| Stockholders Equity | Q2 2023 · Dec 31, 2022 | $9.88M |
| Stockholders Equity | Q2 2023 · Sep 30, 2022 | $10.89M |
| Stockholders Equity | Q2 2023 · Dec 31, 2021 | $14.19M |
| Current Liabilities | Q2 2023 · Mar 31, 2023 | $5.8M |
| Current Liabilities | Q2 2023 · Sep 30, 2022 | $7.47M |
| Total Liabilities | Q2 2023 · Mar 31, 2023 | $5.8M |
| Total Liabilities | Q2 2023 · Sep 30, 2022 | $7.47M |
| Current Assets | Q2 2023 · Mar 31, 2023 | $1.41M |
| Current Assets | Q2 2023 · Sep 30, 2022 | $3.69M |
| Total Assets | Q2 2023 · Mar 31, 2023 | $14.94M |
| Total Assets | Q2 2023 · Sep 30, 2022 | $18.36M |
| Eps Diluted | Q2 2023 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q2 2023 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q2 2023 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2023 · Mar 31, 2023 | −$0.01 |
| Net Income | Q2 2023 · Mar 31, 2023 | −$805.65K |
| Net Income | Q2 2023 · Mar 31, 2023 | −$1.94M |
| Net Income | Q2 2023 · Dec 31, 2022 | −$1.13M |
| Net Income | Q2 2023 · Dec 31, 2021 | −$1.94M |
| Operating Income | Q2 2023 · Mar 31, 2023 | −$806.36K |
| Operating Income | Q2 2023 · Mar 31, 2023 | −$1.94M |
| Gross Profit | Q2 2023 · Mar 31, 2023 | $147.96K |
| Gross Profit | Q2 2023 · Mar 31, 2023 | $93.09K |
| Cost Of Revenue | Q2 2023 · Mar 31, 2023 | $5.49M |
| Cost Of Revenue | Q2 2023 · Mar 31, 2023 | $10.92M |
| Revenue | Q2 2023 · Mar 31, 2023 | $5.63M |
| Revenue | Q2 2023 · Mar 31, 2023 | $11.01M |
| Short Term Debt | Q2 2023 · Mar 1, 2023 | $17.5K |